Drug Description in Trials / DrugBank / KEGG DRUG

Search results

descriptions per page:

Showing 1 to 10 of 27 descriptions

Filter by |

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

-

-

-

-

[3] 5, 7, 127 💬

2

[1] Fludeoxyglucose (18F)

-

-

-

[8] 5, 6, 7, 13, 84, 85, 127, 300 💬

Disease ID	Name
5	Progressive supranuclear palsy
6	Parkinson disease
7	Corticobasal degeneration
13	Multiple sclerosis/Neuromyelitis optica
84	Sarcoidosis
85	Idiopathic interstitial pneumonia
127	Frontotemporal lobar degeneration
300	IgG4-related disease

3

-

-

-

-

[3] 5, 7, 127 💬

4

-

-

-

-

[2] 5, 7 💬

5

-

-

-

-

[11] 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127 💬

Disease ID	Name
5	Progressive supranuclear palsy
6	Parkinson disease
7	Corticobasal degeneration
13	Multiple sclerosis/Neuromyelitis optica
28	Systemic amyloidosis
51	Scleroderma
67	Polycystic kidney disease
86	Pulmonary arterial hypertension
97	Ulcerative colitis
114	Non-dystrophic myotonia syndrome
127	Frontotemporal lobar degeneration

6

Anti-Parkinson medication

-

-

-

-

[5] 5, 6, 7, 8, 17 💬

7

[1] Apomorphine

[1] Apomorphine 💬

[2] DRD1,
DRD2 💬

[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic s ...

[3] 5, 6, 7 💬

8

-

-

-

-

[3] 5, 7, 127 💬

9

BOTULINUM TOXIN TYPE A

[1] Botulinum toxin type A

[1] Botulinum toxin type A 💬

[1] SNAP25 💬

[2] Insulin secretion, Synaptic vesicle cycle 💬

[10] 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 💬

Disease ID	Name
2	Amyotrophic lateral sclerosis
5	Progressive supranuclear palsy
6	Parkinson disease
7	Corticobasal degeneration
13	Multiple sclerosis/Neuromyelitis optica
15	Inclusion body myositis
17	Multiple system atrophy
70	Spinal stenosis
113	Muscular dystrophy
149	Hemiconvulsion hemiplegia epilepsy syndrome

10

[1] Davunetide 💬

-

-

[3] 5, 7, 127 💬

First Previous1 2 3Next Last